(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a- hexahydro naphthalen-1-yl (2S)-2-methylbutanoate (lovastatin).
|
|
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a- hexahydro naphthalen-1-yl (2S)-2-methylbutanoate (lovastatin). 속성
안전
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a- hexahydro naphthalen-1-yl (2S)-2-methylbutanoate (lovastatin). C화학적 특성, 용도, 생산
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a- hexahydro naphthalen-1-yl (2S)-2-methylbutanoate (lovastatin). 준비 용품 및 원자재
원자재
준비 용품
(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a- hexahydro naphthalen-1-yl (2S)-2-methylbutanoate (lovastatin). 공급 업체
글로벌( 1)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
Clinse Labs Private Limited. | -- |
India | 372 | 30 |